COPD
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and female aged 40-79 years old; 2. with cough, cough or difficulty breathing, chest imaging examination with emphysema performance, lung function criteria include: FEV1/FVC ratio <=70% after inhalation of bronchodilator.
Exclusion criteria
Exclusion criteria: 1. The required information is incomplete; 2. patients with respiratory diseases other than chronic obstructive pulmonary disease, such as asthma, interstitial pneumonia, active tuberculosis, community-acquired pneumonia, lung cancer, bronchiectasis, pulmonary heart disease, pulmonary embolism, etc.; 3. abuse of alcohol or narcotic drugs, history of drug abuse, or history of mental illness (such as schizophrenia, obsessive-compulsive disorder, depression), confrontationality, bad motivation, suspiciousness or other emotional or intellectual problems may affect the informed validity of participation in the study Case; 4. Participating in other drug clinical trial projects, or stopping for less than 3 months; 5. patients can not cooperate with the relevant inspection of the project, do not agree to sign informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HRCT; | — |
Secondary
| Measure | Time frame |
|---|---|
| Lung function; | — |
Countries
China
Contacts
The Affilated Hospitial of Guangdong Medical University